お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、オリゴヌクレオチドの合成の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にオリゴヌクレオチドの合成市場を分類しています。
本レポートでは世界のオリゴヌクレオチドの合成市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Integrated DNA Technologies、Merck、Eurofins Genomics、Thermo Fisher Scientific、Agilent Technologies、Eurogentec、GE Healthcare、LGC Biosearch Technologies、Nitto Denko Avecia、Genscript、Genedesign、TriLink Biotechnologies、Bio-Synthesis、ATDBio

レポートはオリゴヌクレオチドの合成の主要生産者を調査し、主要地域や国の消費状況も提供します。オリゴヌクレオチドの合成の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Custom Oligonucleotides
    Pre-designed Oligonucleotides

用途別の市場セグメント：
    Academic Research Institutes
    Pharmaceutical and Biotechnology Companies
    Diagnostic Laboratories
    Others

本レポートの詳細内容
本レポートは、世界のオリゴヌクレオチドの合成市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてオリゴヌクレオチドの合成市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）のオリゴヌクレオチドの合成生産量、成長率、市場シェアを調査している。

二. 消費面では、オリゴヌクレオチドの合成の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーのオリゴヌクレオチドの合成売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のオリゴヌクレオチドの合成市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本オリゴヌクレオチドの合成のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：オリゴヌクレオチドの合成のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： オリゴヌクレオチドの合成の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおけるオリゴヌクレオチドの合成の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章オリゴヌクレオチドの合成メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：オリゴヌクレオチドの合成の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：オリゴヌクレオチドの合成の主要メーカーの概要を提供し、製品の説明と仕様、オリゴヌクレオチドの合成の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：オリゴヌクレオチドの合成の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.
Market Analysis and Insights: Global Oligonucleotide Synthesis Market
The global Oligonucleotide Synthesis market is projected to grow from US$ 2030.5 million in 2024 to US$ 2946.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period.
Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.
Report Covers:
This report presents an overview of global market for Oligonucleotide Synthesis market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Oligonucleotide Synthesis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oligonucleotide Synthesis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oligonucleotide Synthesis revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oligonucleotide Synthesis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by End User, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oligonucleotide Synthesis revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Integrated DNA Technologies, Merck, Eurofins Genomics, Thermo Fisher Scientific, Agilent Technologies, Eurogentec, GE Healthcare, LGC Biosearch Technologies and Nitto Denko Avecia, etc.

Market Segmentation
By Company
    Integrated DNA Technologies
    Merck
    Eurofins Genomics
    Thermo Fisher Scientific
    Agilent Technologies
    Eurogentec
    GE Healthcare
    LGC Biosearch Technologies
    Nitto Denko Avecia
    Genscript
    Genedesign
    TriLink Biotechnologies
    Bio-Synthesis
    ATDBio

Segment by Type
    Custom Oligonucleotides
    Pre-designed Oligonucleotides

Segment by End User
    Academic Research Institutes
    Pharmaceutical and Biotechnology Companies
    Diagnostic Laboratories
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Oligonucleotide Synthesis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Synthesis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by End User and by country, revenue for each segment.
Chapter 7: Europe by Type, by End User and by country, revenue for each segment.
Chapter 8: China by Type, and by End User, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by End User and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by End User and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oligonucleotide Synthesis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Custom Oligonucleotides
    Table 3. Key Players of Pre-designed Oligonucleotides
    Table 4. Global Oligonucleotide Synthesis Market Size Growth Rate by End User (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Oligonucleotide Synthesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Oligonucleotide Synthesis Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Oligonucleotide Synthesis Market Share by Region (2019-2024)
    Table 8. Global Oligonucleotide Synthesis Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Oligonucleotide Synthesis Market Share by Region (2025-2030)
    Table 10. Oligonucleotide Synthesis Market Trends
    Table 11. Oligonucleotide Synthesis Market Drivers
    Table 12. Oligonucleotide Synthesis Market Challenges
    Table 13. Oligonucleotide Synthesis Market Restraints
    Table 14. Global Oligonucleotide Synthesis Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Oligonucleotide Synthesis Revenue Share by Players (2019-2024)
    Table 16. Global Top Oligonucleotide Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Synthesis as of 2023)
    Table 17. Global Oligonucleotide Synthesis Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Oligonucleotide Synthesis, Headquarters and Area Served
    Table 20. Global Key Players of Oligonucleotide Synthesis, Product and Application
    Table 21. Global Key Players of Oligonucleotide Synthesis, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Oligonucleotide Synthesis Revenue Market Share by Type (2019-2024)
    Table 25. Global Oligonucleotide Synthesis Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Oligonucleotide Synthesis Revenue Market Share by Type (2025-2030)
    Table 27. Global Oligonucleotide Synthesis Market Size by End User (2019-2024) & (US$ Million)
    Table 28. Global Oligonucleotide Synthesis Revenue Share by End User (2019-2024)
    Table 29. Global Oligonucleotide Synthesis Forecasted Market Size by End User (2025-2030) & (US$ Million)
    Table 30. Global Oligonucleotide Synthesis Revenue Share by End User (2025-2030)
    Table 31. North America Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Oligonucleotide Synthesis Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Oligonucleotide Synthesis Market Size by End User (2019-2024) & (US$ Million)
    Table 34. North America Oligonucleotide Synthesis Market Size by End User (2025-2030) & (US$ Million)
    Table 35. North America Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Oligonucleotide Synthesis Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Oligonucleotide Synthesis Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Oligonucleotide Synthesis Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Oligonucleotide Synthesis Market Size by End User (2019-2024) & (US$ Million)
    Table 41. Europe Oligonucleotide Synthesis Market Size by End User (2025-2030) & (US$ Million)
    Table 42. Europe Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Oligonucleotide Synthesis Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Oligonucleotide Synthesis Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Oligonucleotide Synthesis Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Oligonucleotide Synthesis Market Size by End User (2019-2024) & (US$ Million)
    Table 48. China Oligonucleotide Synthesis Market Size by End User (2025-2030) & (US$ Million)
    Table 49. Asia Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Oligonucleotide Synthesis Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Oligonucleotide Synthesis Market Size by End User (2019-2024) & (US$ Million)
    Table 52. Asia Oligonucleotide Synthesis Market Size by End User (2025-2030) & (US$ Million)
    Table 53. Asia Oligonucleotide Synthesis Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Oligonucleotide Synthesis Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Oligonucleotide Synthesis Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by End User (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by End User (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Integrated DNA Technologies Company Details
    Table 64. Integrated DNA Technologies Business Overview
    Table 65. Integrated DNA Technologies Oligonucleotide Synthesis Product
    Table 66. Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 67. Integrated DNA Technologies Recent Developments
    Table 68. Merck Company Details
    Table 69. Merck Business Overview
    Table 70. Merck Oligonucleotide Synthesis Product
    Table 71. Merck Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 72. Merck Recent Developments
    Table 73. Eurofins Genomics Company Details
    Table 74. Eurofins Genomics Business Overview
    Table 75. Eurofins Genomics Oligonucleotide Synthesis Product
    Table 76. Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 77. Eurofins Genomics Recent Developments
    Table 78. Thermo Fisher Scientific Company Details
    Table 79. Thermo Fisher Scientific Business Overview
    Table 80. Thermo Fisher Scientific Oligonucleotide Synthesis Product
    Table 81. Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 82. Thermo Fisher Scientific Recent Developments
    Table 83. Agilent Technologies Company Details
    Table 84. Agilent Technologies Business Overview
    Table 85. Agilent Technologies Oligonucleotide Synthesis Product
    Table 86. Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 87. Agilent Technologies Recent Developments
    Table 88. Eurogentec Company Details
    Table 89. Eurogentec Business Overview
    Table 90. Eurogentec Oligonucleotide Synthesis Product
    Table 91. Eurogentec Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 92. Eurogentec Recent Developments
    Table 93. GE Healthcare Company Details
    Table 94. GE Healthcare Business Overview
    Table 95. GE Healthcare Oligonucleotide Synthesis Product
    Table 96. GE Healthcare Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 97. GE Healthcare Recent Developments
    Table 98. LGC Biosearch Technologies Company Details
    Table 99. LGC Biosearch Technologies Business Overview
    Table 100. LGC Biosearch Technologies Oligonucleotide Synthesis Product
    Table 101. LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 102. LGC Biosearch Technologies Recent Developments
    Table 103. Nitto Denko Avecia Company Details
    Table 104. Nitto Denko Avecia Business Overview
    Table 105. Nitto Denko Avecia Oligonucleotide Synthesis Product
    Table 106. Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 107. Nitto Denko Avecia Recent Developments
    Table 108. Genscript Company Details
    Table 109. Genscript Business Overview
    Table 110. Genscript Oligonucleotide Synthesis Product
    Table 111. Genscript Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 112. Genscript Recent Developments
    Table 113. Genedesign Company Details
    Table 114. Genedesign Business Overview
    Table 115. Genedesign Oligonucleotide Synthesis Product
    Table 116. Genedesign Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 117. Genedesign Recent Developments
    Table 118. TriLink Biotechnologies Company Details
    Table 119. TriLink Biotechnologies Business Overview
    Table 120. TriLink Biotechnologies Oligonucleotide Synthesis Product
    Table 121. TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 122. TriLink Biotechnologies Recent Developments
    Table 123. Bio-Synthesis Company Details
    Table 124. Bio-Synthesis Business Overview
    Table 125. Bio-Synthesis Oligonucleotide Synthesis Product
    Table 126. Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 127. Bio-Synthesis Recent Developments
    Table 128. ATDBio Company Details
    Table 129. ATDBio Business Overview
    Table 130. ATDBio Oligonucleotide Synthesis Product
    Table 131. ATDBio Revenue in Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
    Table 132. ATDBio Recent Developments
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oligonucleotide Synthesis Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Oligonucleotide Synthesis Market Share by Type: 2023 VS 2030
    Figure 3. Custom Oligonucleotides Features
    Figure 4. Pre-designed Oligonucleotides Features
    Figure 5. Global Oligonucleotide Synthesis Market Size Growth Rate by End User, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Oligonucleotide Synthesis Market Share by End User: 2023 VS 2030
    Figure 7. Academic Research Institutes Case Studies
    Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
    Figure 9. Diagnostic Laboratories Case Studies
    Figure 10. Others Case Studies
    Figure 11. Oligonucleotide Synthesis Report Years Considered
    Figure 12. Global Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Oligonucleotide Synthesis Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Oligonucleotide Synthesis Market Share by Region: 2023 VS 2030
    Figure 15. Global Oligonucleotide Synthesis Market Share by Players in 2023
    Figure 16. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Synthesis as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Oligonucleotide Synthesis Revenue in 2023
    Figure 18. North America Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Oligonucleotide Synthesis Market Share by Type (2019-2030)
    Figure 20. North America Oligonucleotide Synthesis Market Share by End User (2019-2030)
    Figure 21. North America Oligonucleotide Synthesis Market Share by Country (2019-2030)
    Figure 22. United States Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Oligonucleotide Synthesis Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Oligonucleotide Synthesis Market Share by Type (2019-2030)
    Figure 26. Europe Oligonucleotide Synthesis Market Share by End User (2019-2030)
    Figure 27. Europe Oligonucleotide Synthesis Market Share by Country (2019-2030)
    Figure 28. Germany Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Oligonucleotide Synthesis Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Oligonucleotide Synthesis Market Share by Type (2019-2030)
    Figure 36. China Oligonucleotide Synthesis Market Share by End User (2019-2030)
    Figure 37. Asia Oligonucleotide Synthesis Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Oligonucleotide Synthesis Market Share by Type (2019-2030)
    Figure 39. Asia Oligonucleotide Synthesis Market Share by End User (2019-2030)
    Figure 40. Asia Oligonucleotide Synthesis Market Share by Region (2019-2030)
    Figure 41. Japan Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Share by End User (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Oligonucleotide Synthesis Market Share by Country (2019-2030)
    Figure 51. Brazil Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 58. Merck Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 59. Eurofins Genomics Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 61. Agilent Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 62. Eurogentec Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 63. GE Healthcare Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 64. LGC Biosearch Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 65. Nitto Denko Avecia Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 66. Genscript Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 67. Genedesign Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 68. TriLink Biotechnologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 69. Bio-Synthesis Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 70. ATDBio Revenue Growth Rate in Oligonucleotide Synthesis Business (2019-2024)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed